Trial of solriamfetol for excessive sleepiness
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study tests a new medication called solriamfetol to see if it safely reduces excessive daytime sleepiness in people with idiopathic hypersomnia. You may receive the study drug or a placebo, and your sleepiness levels will be monitored to see if the treatment helps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- Your body mass index (BMI) should be between 18 and 30.
- You need a diagnosis of idiopathic hypersomnia (excessive sleepiness without a clear cause) made in the last 5 years, confirmed by sleep tests.
- Your sleep tests should show specific patterns, like falling asleep quickly or sleeping more than 11 hours a day.
- You must not have other sleep disorders like sleep apnea or significant movement during sleep.
- You must not be taking certain medications for sleepiness, depression, or other psychiatric conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether low-dose sodium oxybate can improve symptoms in adults with idiopathic hypersomnia, a condition that causes excessive sleepiness. You’d likely be asked to pause this standard treatment briefly while baseline testing is completed, and you’d use reliable contraception during and after the study drug.
This trial tests a new medication, HBS-301, in people with idiopathic hypersomnia (a condition causing excessive sleepiness without clear cause). It aims to see if the drug improves wakefulness and is safe.
This trial tests whether taking melatonin at night and using a bright light therapy device in the morning can improve excessive daytime sleepiness in people with idiopathic hypersomnia. It is a double-blind study, meaning neither you nor the doctors will know if you are getting the real treatment or a placebo.
This trial tests an experimental drug called ORX750 for people with narcolepsy or idiopathic hypersomnia. You would need to stop your current sleepiness medicines to see if ORX750 helps reduce daytime sleepiness.
This study is building a long-term group of people with chronic excessive sleepiness (hypersomnolence) so researchers can better understand rare sleep disorders and related biology. It involves sleep-focused assessments and questionnaires, and you may or may not be on treatment for sleep problems.
This trial tests whether a structured patient education program helps people with chronic insomnia sleep better and feel better. You would likely learn sleep-focused strategies and receive support aimed at improving sleep habits.
Hear when a new Idiopathic Hypersomnia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.